<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;13 or 15(d)
of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<U>June 15, 2012</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>IVAX Diagnostics, Inc.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; padding-right: 0; padding-left: 0">Delaware</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; padding-right: 0; padding-left: 0">1-14798</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; padding-right: 0; padding-left: 0">11-3500746</TD></TR>
<TR>
    <TD STYLE="text-align: center; padding-right: 0; padding-left: 0">(State or other jurisdiction <BR> of incorporation)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-right: 0; padding-left: 0">(Commission<BR> File Number)</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-right: 0; padding-left: 0">(IRS Employer<BR> Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: Black 1pt solid; padding-right: 0; padding-left: 0">2140 North Miami Avenue, <BR> Miami, Florida</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1pt solid; padding-right: 0; padding-left: 0">33127</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center; padding-right: 0; padding-left: 0">(Address of principal executive offices)</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-right: 0; padding-left: 0">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <U>305-324-2300</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Not Applicable<BR>
</U>(Former name or former address, if changed since last report.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; font-family: Wingdings">o</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; font-family: Wingdings">o</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">Soliciting material pursuant to Rule&nbsp;14a&#45;12 under the Exchange Act (17 CFR 240.14a&#45;12)</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; font-family: Wingdings">o</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">Pre-commencement communications pursuant to Rule&nbsp;14d&#45;2(b) under the Exchange Act (17 CFR 240.14d&#45;2(b))</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; font-family: Wingdings">o</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0">Pre-commencement communications pursuant to Rule&nbsp;13e&#45;4(c) under the Exchange Act (17 CFR 240.13e&#45;4(c))</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%; padding-right: 0; padding-left: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%; padding-right: 0; padding-left: 0">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.75pt; text-indent: -53.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.75pt; text-indent: -53.75pt"><B>Item 5.02 &nbsp;Departure of
Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 15, 2012, IVAX Diagnostics, Inc.
(the &ldquo;Company&rdquo;) and Kevin D. Clark agreed to continue Mr. Clark&rsquo;s current roles as the Company&rsquo;s President,
Chief Executive Officer and Chief Operating Officer without a definitive expiration date, such that <FONT STYLE="color: black">Mr.
Clark&rsquo;s existing employment is no longer scheduled to come to an end on June 30, 2012, as previously disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The type of Mr. Clark&rsquo;s
employment as the Company&rsquo;s President, Chief Executive Officer and Chief Operating Officer beyond <FONT STYLE="color: black">June
30, 2012</FONT>, which was unanimously approved on June 15, 2012 by the Compensation Committee and the Board of Directors of the
Company, <FONT STYLE="color: black">continues to be &lsquo;at-will&rsquo;, without any employment agreement,</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
</FONT><FONT STYLE="color: black">and may be terminated by Mr. </FONT>Clark<FONT STYLE="color: black"> or the Company at any time.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Item&nbsp;5.07 &nbsp;<B>Submission of Matters to a Vote of Security Holders.</B>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2012 Annual Meeting
of Stockholders of the Company was held on June 15, 2012. At the Annual Meeting, the Company&rsquo;s stockholders voted on two
matters with the following results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">1.&#9;The Company&rsquo;s
stockholders elected two directors to the Company&rsquo;s Board of Directors, each to serve for a three-year term expiring at the
Company&rsquo;s 2015 Annual Meeting of Stockholders. The two director nominees were elected by the Company&rsquo;s stockholders
by the following votes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
<TR>
    <TD NOWRAP STYLE="width: 43%; vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 0; padding-left: 0; font-weight: bold">Director</TD>
    <TD STYLE="width: 3%; vertical-align: top; padding-right: 0; padding-left: 0; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 13%; vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Votes</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For</B></P></TD>
    <TD STYLE="width: 3%; vertical-align: top; padding-right: 0; padding-left: 0; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 15%; vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR>
        <B>Votes</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Withheld</B></P></TD>
    <TD STYLE="width: 3%; vertical-align: top; padding-right: 0; padding-left: 0; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 20%; vertical-align: bottom; border-bottom: windowtext 1pt solid; padding-right: 0; padding-left: 0; font-weight: bold; text-align: center">Broker<BR> Non-Votes</TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,255,204)">
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">Gerald E. Gallwas</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: center">28,844,434</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: center">50,577</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: center">4,545,421</TD></TR>
<TR STYLE="background-color: White">
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0">David M. Templeton</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: center">28,844,000</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: center">51,011</TD>
    <TD STYLE="vertical-align: top; padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; padding-right: 0; padding-left: 0; text-align: center">4,545,421</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">2.&#9;The Company&rsquo;s
stockholders approved the amendment of the Company&rsquo;s Amended and Restated Certificate of Incorporation changing the Company&rsquo;s
name to &ldquo;ERBA Diagnostics, Inc.&rdquo; The Company&rsquo;s stockholders voted as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 25%; border-bottom: windowtext 1pt solid; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR>
        <B>Votes</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For</B></P></TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: windowtext 1pt solid; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Votes</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Against</B></P></TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: windowtext 1pt solid; padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Abstained</B></P></TD>
    <TD STYLE="width: 2%; padding-right: 0; padding-left: 0; font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: windowtext 1pt solid; padding-right: 0; padding-left: 0; font-weight: bold; text-align: center">Broker<BR> Non-Votes</TD></TR>
<TR>
    <TD NOWRAP STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD NOWRAP STYLE="padding-right: 0; padding-left: 0; text-align: center">33,275,589</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-left: 0; text-align: center">164,343</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center">500</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="padding-right: 0; padding-left: 0; text-align: center">0</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8.01</B> <B>Other Events.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company announced
today that its corporate name has been changed to &ldquo;ERBA Diagnostics, Inc.&rdquo; As discussed above, the name change was
approved by the Company&rsquo;s stockholders at the Annual Meeting of Stockholders held on June 15, 2012. The Company&rsquo;s Board
of Directors previously approved the name change, and recommended that the Company&rsquo;s stockholders approve the name change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s
Board of Directors believes that the name change would be in the best interests of the Company and its stockholders. The new name
would reflect the strong relationship that the Company enjoys with its majority stockholder&nbsp;&mdash;&nbsp;ERBA Diagnostics
Mannheim GmbH, an emerging multi-national company operating in the core business segment of in vitro diagnostics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the name change, the ticker symbol of the Company&rsquo;s common stock, par value $0.01, on the NYSE MKT (formerly known as the
NYSE Amex) will change from &ldquo;IVD&rdquo; to &ldquo;ERB.&rdquo; Trading under the new ticker symbol, &ldquo;ERB,&rdquo; is
planned to begin at market-open on Monday, June 18, 2012.</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%; padding-right: 0; padding-left: 0">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%; padding-right: 0; padding-left: 0">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>SIGNATURES </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-right: 0; padding-left: 0">Date: June 15, 2012&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0">IVAX Diagnostics, Inc.<BR> </TD></TR>
<TR>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 50%; padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-right: 0; padding-left: 0">By:&nbsp;&nbsp;</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid; padding-right: 0; padding-left: 0">/s/ Kevin D. Clark</TD></TR>
<TR>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">Name:&nbsp;&nbsp; Kevin D. Clark,&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title: &nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief
        Operating Officer and President&nbsp;</P></TD></TR>
<TR>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%; padding-right: 0; padding-left: 0">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v316195_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 25504}]
{"company-data": {"conformed-name": "IVAX DIAGNOSTICS INC", "cik": "0001095858", "assigned-sic": "2834", "irs-number": "113500746", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-14798", "film-number": "12910341"}, "business-address": {"street1": "2140 NORTH MIAMI AVENUE", "city": "MIAMI", "state": "FL", "zip": "90802", "phone": "5624917180"}, "mail-address": {"street1": "2140 NORTH MIAMI AVENUE", "city": "MIAMI", "state": "FL", "zip": "33127"}, "former-company": {"former-conformed-name": "B2BSTORES COM INC", "date-changed": "19990928"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 15, 2012
IVAX Diagnostics, Inc.
(Exact name of registrant as specified in
its charter)
Delaware
1-14798
11-3500746
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
2140 North Miami Avenue,
Miami, Florida
33127
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including
area code:
305-324-2300
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02  Departure of
Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 15, 2012, IVAX Diagnostics, Inc.
(the "Company") and Kevin D. Clark agreed to continue Mr. Clark's current roles as the Company's President,
Chief Executive Officer and Chief Operating Officer without a definitive expiration date, such that
Mr.
Clark's existing employment is no longer scheduled to come to an end on June 30, 2012, as previously disclosed.
The type of Mr. Clark's
employment as the Company's President, Chief Executive Officer and Chief Operating Officer beyond
June
30, 2012
, which was unanimously approved on June 15, 2012 by the Compensation Committee and the Board of Directors of the
Company,
continues to be 'at-will', without any employment agreement,
and may be terminated by Mr.
Clark
or the Company at any time.
Item 5.07
Submission of Matters to a Vote of Security Holders.
The 2012 Annual Meeting
of Stockholders of the Company was held on June 15, 2012. At the Annual Meeting, the Company's stockholders voted on two
matters with the following results.
1.	The Company's
stockholders elected two directors to the Company's Board of Directors, each to serve for a three-year term expiring at the
Company's 2015 Annual Meeting of Stockholders. The two director nominees were elected by the Company's stockholders
by the following votes:
Director
Votes
For
Votes
Withheld
Broker
Non-Votes
Gerald E. Gallwas
28,844,434
50,577
4,545,421
David M. Templeton
28,844,000
51,011
4,545,421
2.	The Company's
stockholders approved the amendment of the Company's Amended and Restated Certificate of Incorporation changing the Company's
name to "ERBA Diagnostics, Inc." The Company's stockholders voted as follows:
Votes
For
Votes
Against
Abstained
Broker
Non-Votes
33,275,589
164,343
500
0
Item 8.01
Other Events.
The Company announced
today that its corporate name has been changed to "ERBA Diagnostics, Inc." As discussed above, the name change was
approved by the Company's stockholders at the Annual Meeting of Stockholders held on June 15, 2012. The Company's Board
of Directors previously approved the name change, and recommended that the Company's stockholders approve the name change.
The Company's
Board of Directors believes that the name change would be in the best interests of the Company and its stockholders. The new name
would reflect the strong relationship that the Company enjoys with its majority stockholder — ERBA Diagnostics
Mannheim GmbH, an emerging multi-national company operating in the core business segment of in vitro diagnostics.
In connection with
the name change, the ticker symbol of the Company's common stock, par value $0.01, on the NYSE MKT (formerly known as the
NYSE Amex) will change from "IVD" to "ERB." Trading under the new ticker symbol, "ERB," is
planned to begin at market-open on Monday, June 18, 2012.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: June 15, 2012
IVAX Diagnostics, Inc.
By:
/s/ Kevin D. Clark
Name:   Kevin D. Clark,
Title:     Chief Executive Officer,
Chief
        Operating Officer and President